Alimorad Farshchian, M.D., founder and medical director of The Center for Regenerative Medicine, founded in 1999.
A Miami doctor who has developed an international reputation for medical innovation over the last 18 years has become a pioneer in the burgeoning and critically important field of stem cell therapy.
Alimorad Farshchian, M.D., founder and medical director of The Center for Regenerative Medicine, founded in 1999, has developed innovative, safe and effective stem cell treatments for Parkinsons Disease, spinal stenosis and other physical ailments, such as back and knee problems. More recently, he has developed stem cell-derived eye drops that have successfully treated a range of eye disorders, including retinitis pigmentosa.
Since 2006, Dr. Farshchian has treated more than 11,000 patients in more than 50countries with his proprietary stem cell therapies. Despite his major innovation and success with stem cell therapies, he is best-known worldwide for successfully treating the late Michael Jackson for his addiction to prescription painkillers and also for an ankle injury before what would have been the new tour Jackson planned before his death.
Stem cells are the bodys most fundamental raw materials the cells from which all other cells with specialized functions are generated. They either become new stem cells or specialized cells, such as retina cells for the eyes. No other cell in the human body has the ability to generate new types of cells that address specific bodily functions.
Beginning in 1999, Dr. Farshchian, a member of the American Academy ofAnti-Aging Medicine, began a quest to develop new and more effective treatments forneurodegenerative diseases such as Parkinsons Disease. In 2006, he began experimenting with revolutionary stem cell treatments that involve using the patients own stem cells, known as autologous stem cells, which are reinjected into the patients body after minimal processing.
Ive experienced great improvement as a result of the stem cell treatments, says 62-year-old Sharon Davis of Cocoa, Florida, who was diagnosed with Parkinsons Disease three and a half years ago. After taking medications for more than three years that did not eliminate her symptoms and also had unpleasant side effects, she sought out Dr. Farshchian after he successfully treated her 37-year-old daughter, Heather Fleckinger, who had suffered from chronic and severe lower back problems for five years.
A series of three monthly stem cell injections significantly relieved Ms. Daviss symptoms, especially the shaking she was experiencing on her right side, and reduced her need for prescription medications. Based on how much he helped me, I tell everybody I know to go see him, says Ms. Davis, who is continuing treatment in the hope her symptoms will be completely alleviated, ending her need for any medications.
Her daughter, Ms. Fleckinger, says, I feel like Dr. Farshchian saved my life. Before I went to see him, I wore a back brace and took daily medications, but my back problems still prevented me from doing my job as a horse trainer and I had to wear a back brace almost constantly. Over a five-year period, I also tried chiropractors and acupuncture, but nothing worked.
Then, she says, a series of three stem cell injections from Dr. Farshchian over a one-week period cured her. Within three weeks, my back felt much better, she says. And after four weeks, it didnt hurt at all. I could hardly believe it. I consider it a miracle. She returns for follow-up booster shots every six to 12 months.
Rose Rubino, a 69-year-old business owner from Cape Canaveral, has been treated with Dr. Farshchians stem cell therapies over the last seven years for knee problems, severe arthritis, and spinal stenosis.
The first time I went to see him, I was scheduled for knee replacement surgery,Ms. Rubino says. But I ended up being able to avoid surgery because of the incredible resultI got from the stem cell injections. She received three injections over a one-week period.
Three months later, her 54-year-old sister suffered a frozen shoulder. Doctors told herthe condition required arthroscopic surgery. Instead, based on Ms. Rubinos recommendation, she saw Dr. Farshchian, who treated her successfully with a single stem cell injection. So shewas able to avoid surgery, just like I was, Ms. Rubino says.
Over the past five years, Dr. Farshchian has also successfully treated Ms. Rubino for arthritis and spinal stenosis. Dr. Farshchian saved my life, as far as Im concerned, she says. Nobody ever told me that as I aged, I would develop all these painful physical ailments that would supposedly require surgery. And every time, Dr. Farshchians stem cell treatments worked. I consider myself his unofficial spokesperson, because as far as Im concerned he performed multiple miracles in my life. So I tell the world about him, every chance I get.
Dr. Farshchians latest progress is in the field of optical regeneration. He has developed proprietary eye drops, trademarked as iFarshchian Drops, to treat retinitis pigmentosa, a genetic disorder that involves a breakdown and loss of cells in the retina.
The drops are uniquely developed for each patient from his or her own stem cells and are engineered to penetrate the sclera, or white outer layer of the eyeball, in order to find damaged eye cells and rejuvenate them.
Dr. Farshchian stresses that recently reported and serious complications from therapy at a South Florida clinic that injected stem cells into the eyes of patients were the result of flawed delivery of the therapy, rather than the therapy itself, which has been proven safe and successful in ongoing clinical trials at University of California at Irvine and at RIKEN Laboratory in Kobe, Japan. He also emphasizes that his eye drops are less invasive and safer than injections.
This spring, Dr. Farshchians eye drops successfully treated 89-year-old James
Enochs of Prince George, VA for degenerative eye disease. Ive already had significant improvement in my ability to read an eye chart, says Enochs, who was successfully treated with stem cell therapy by Dr. Farshchian for chronic knee problems seven years ago. My eyes had been very sensitive to wind and light. And Ive noticed a significant improvement in that sensitivity. I can only speak about the eye drops from my own experience. But for me,they have already delivered pretty remarkable results. He will now continue to use the dropsat home.Dr. Farshchian is a very brilliant and innovative doctor, Enochs says. I was justabout as skeptical as you could be the first time I came to Miami seven years ago fortreatment on my knees. But I had a huge success with my knees, and was able to avoid thesurgery that my orthopedist wanted to perform. Now Ive also had success with my eyes.So Im very impressed with his work with stem cells. Im not a skeptic anymore. Because Dr. Farshchian uses only autologous stem cells those taken from a patients own body the therapies are neither restricted nor regulated by the Food & Drug Administration. But, Dr. Farshchian points out, he fully complies with all stem cell-related FDA recommendations.
The three primary disorders that I treat with stem cells retinitis pigmentosa, Parkinsons Disease, and spinal stenosis, are difficult to treat traditionally because they are stubbornly resistant to surgery, Dr. Farshchian says. That means that most patients with those conditions are in dire need of a new alternative that works. And very few of them are aware yet of the dramatic breakthroughs being made with stem cell therapies.
His stem cell treatments are not Dr. Farshchians first major medical innovation. Almost 20 years ago, he coined the term orthopedic regenerative medicine to describe the highly effective new treatments he developed for common ailments such as arthritis.
The Center for Regenerative Medicine is located at 1001 NE 125th Street in North Miami. For more information , call (305) 891-4686 or visit ArthritisUSA.net.
Connect To Your Customers & Grow Your Business
Read this article:
Miami Doctor Pioneers Innovative Stem Cell Therapies For Parkinson's Disease, Spinal Stenosis And Degenerative ... - Miami's Community Newspapers
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021